1 day J&J’s Q4 Earnings Beat, Stock Down on Tepid 2025 Sales Guidance Zacks
JNJ beats estimates for fourth-quarter earnings and sales. Its sales guidance for 2025 falls short of expectations.
Earnings · Johnson & Johnson (JNJ)
XJNJ beats estimates for fourth-quarter earnings and sales. Its sales guidance for 2025 falls short of expectations.
Earnings · Johnson & Johnson (JNJ)
X